Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
Related Questions
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
Would you proceed with anti-CD20 treatment in an MS patient who is VZV IgG negative in spite of vaccination in the last year?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
What biomarkers best predict the response to B-cell depleting therapies in MS?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
